The Dutch pharmaceutical mail-order company DocMorris would like to cooperate with local pharmacies in Germany in the future, even before the legal introduction of the e-prescription for 2021. Until now, the discounts that mail-order companies offer on prescription drugs have always been a source of controversy. This is now to end, as Rx-Boni will only grant DocMorris to long-standing existing customers. DocMorris wants to revolutionise the supply of medicines in the future and is, therefore, planning a digital medicine platform, also for partnership-based cooperation with German stationary pharmacies. According to the mail-order company’s idea, customers of local pharmacies will in future be able to order their medicines via the new platform and then have the medicines picked up at the pharmacy of their choice or delivered by courier service. DocMorris CEO Olaf Heinrich believes that both cooperation partners will benefit in this way, especially since sales of e-prescriptions will be handled by stationary pharmacies in 90 percent of cases; only ten percent of customers will be supplied directly by DocMorris‘ mail-order business. Ultimately, it will always be the patient who decides how and where he wants to order his medicines and receive advice, as this is still best done by the local pharmacy whose employees have built up a relationship of trust with the customer. Above all, office-pharmacists are afraid of competition from abroad, because they could only have the economic goals of the listed company in mind and could, therefore, direct the flow of customers, also, for example, with the help of over-the-counter brand-strong products from the pharmacy range, which are also offered at low prices.
